Navigation Links
Medarex to Present at the 27th Annual J.P. Morgan Healthcare Conference
Date:1/6/2009

PRINCETON, N.J., Jan. 6 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX) announced today that it is scheduled to present at the 27th Annual J.P. Morgan Healthcare Conference at 8:30 a.m. Pacific Time (11:30 a.m. Eastern Time) on Tuesday, January 13, 2009. The event will be webcast live and will be available in the Investor Relations section of the Medarex website at www.medarex.com. An archived edition of the presentation will be available following the event.

About Medarex

Medarex is a biopharmaceutical company focused on the discovery, development and potential commercialization of fully human antibody-based therapeutics to treat life-threatening and debilitating diseases, including cancer, inflammation, autoimmune disorders and infectious diseases. Medarex applies its UltiMAb(R) technology and product development and clinical manufacturing experience to generate, support and potentially commercialize a broad range of fully human antibody product candidates for itself and its partners. Over forty of these therapeutic product candidates derived from Medarex technology are in human clinical testing or have had INDs submitted for such trials, with the most advanced product candidates currently in Phase 3 clinical trials, the subject of regulatory applications for marketing authorization or approved in Canada. Medarex is committed to building value by developing a diverse pipeline of antibody products to address the world's unmet healthcare needs. For more information about Medarex, visit its website at www.medarex.com.

Medarex(R), the Medarex logo and UltiMAb(R) are registered trademarks of Medarex, Inc. All rights are reserved.

    Contact: Laura S. Choi                   Nichol Ochsner

'/>"/>
SOURCE  Medarex, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 

Related biology technology :

1. Medarex to Present at the RBC Capital Markets Healthcare Conference
2. Medarex and Massachusetts Biologic Laboratories Announce Primary Objective Achieved in Phase 2 Trial of Monoclonal Antibody Combination for the Treatment of Clostridium difficile Associated Diarrhea (CDAD)
3. Medarex Announces 2008 Third Quarter Financial Results
4. Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R)
5. Medarex to Present at the UBS Global Life Sciences Conference
6. Medarex to Present at the Thomas Weisel Partners Healthcare Conference
7. BioWa and Medarex Announce License of BioWas COMPLEGENT(TM) Technology
8. Medarex Announces July 10 Live Webcast of R&D Day Event
9. Medarex to Present at the Jefferies Second Annual Healthcare Conference
10. Medarex to Present at the 29th Annual Goldman Sachs Healthcare Conference
11. Medarex to Present at the Bank of America 2008 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... cardiac pacemakers may inadequately stimulate a patient,s heart ... due to the magnetic pulses mixing with the ... stimulation is potentially dangerous for the patient undergoing ... BioMed Central,s open access journal BioMedical Engineering ... that uses a magnetic field instead of ionizing ...
(Date:12/16/2009)... 16 WaferGen Biosystems, Inc. (OTC Bulletin ... analysis systems, today announced that it will be ... service for gene-expression profiling using its SmartChip(TM) Real-Time ... the most comprehensive human microRNA panel of 885 ... SmartChip service offers customers the use of its ...
(Date:12/16/2009)... -- Capitalizing on the continued strong ... active venture capital market, leaders from BioCrossroads, Eli ... Indiana University, Purdue University, the University of Notre ... today announced the establishment of the INext Fund, ... ,, Organized through BioCrossroads, Indiana,s initiative to grow, ...
(Date:12/16/2009)... Protocol Assessment with the Food and Drug ... - AEterna Zentaris Inc. (NASDAQ: AEZS ... biopharmaceutical company focused on oncology and endocrine ... partner Keryx Biopharmaceuticals Inc. ("Keryx") ( KERX), ... for perifosine (KRX-0401), the Company,s PI3K/Akt pathway ...
Breaking Biology Technology:FDA researchers identify new MRI safety risk for patients with pacemakers 2WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 2WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 3WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 4Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 2Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 3Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 4Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 5AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 2AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 4AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 5
... On October 11, 2005, the Centers for Medicare ... Human Services Office of Inspector General ("OIG") published ... effort to advance the goal of widespread adoption ... and other health care providers. These proposed rules ...
... Healthcare's LightSpeed VCT, the world's first volume ... the Wall Street Journal in the ... Innovation Awards. The annual awards recognize technological breakthroughs ... in a wide range of areas, including medicine. ...
... a significant presence in the bicycle industry by buying ... market. But the Madison, Wis.-based company has jumped full ... frequency identification (RFID) technology into its systems. , ,The ... and Roadmaster along with newer names such as GT ...
Other Biology Technology:The use of e-prescribing and electronic health records is accelerating 2The use of e-prescribing and electronic health records is accelerating 3The use of e-prescribing and electronic health records is accelerating 4The use of e-prescribing and electronic health records is accelerating 5Pacific Cycle rides full speed into RFID 2Pacific Cycle rides full speed into RFID 3
(Date:12/16/2009)... iQor, a global provider of business process ... InfoWorld 100 Awards Top 100 IT project of ... the first submission for iQor. ,, "We are honored ... said Vikas Kapoor, president and CEO of iQor. "TeQ21 ... us to work faster, smarter and with the added ...
(Date:12/16/2009)... HARBOR, Fla., Dec. 2 Communication ... a leading supplier of electronic signature solutions ... industry* and the recognized leader** in biometric ... a leading International Electronic Document Management (EDM) ... entered an agreement to provide their products ...
(Date:12/16/2009)... Texas, Dec. 8, 2009 National ... in industrial measurement and control, and DENSO ... automation using robotics technology, today announced their ... technology with DENSO robotic arms. The collaboration ... research and flexible manufacturing applications. In today,s ...
Breaking Biology News(10 mins):iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 2National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 3National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 4National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 5Garner to Lead Virginia Bioinformatics Institute 14513 1Garner to Lead Virginia Bioinformatics Institute 14513 2Garner to Lead Virginia Bioinformatics Institute 14513 3MedImmune to Present Data on RSV and Influenza at 2009 American Academy of Pediatrics National Conference 26amp 3B Exhibition 5539 1MedImmune to Present Data on RSV and Influenza at 2009 American Academy of Pediatrics National Conference 26amp 3B Exhibition 5539 2MedImmune to Present Data on RSV and Influenza at 2009 American Academy of Pediatrics National Conference 26amp 3B Exhibition 5539 3MedImmune to Present Data on RSV and Influenza at 2009 American Academy of Pediatrics National Conference 26amp 3B Exhibition 5539 4ESC press statement 3A Cigarettes on sale on the internet 59661 1ESC press statement 3A Cigarettes on sale on the internet 59661 2ESC press statement 3A Cigarettes on sale on the internet 59661 3
... in French . , A study appearing ... demonstrates that a synthetic new chemical entity protects against ... enhances exercise endurance by enhancing fat utilization in certain ... developed by Sirtris, a a GSK company, and the ...
... Imagine descending in a submarine to the ice-cold, ink-black ... of the Atlantic. Here the tops of the hills ... studied the formation of these unknown cold-water relatives of ... the development of carbonate mounds dominated by cold-water corals ...
... themselves or as an ingredient in a variety of foods, ... spot in the hearts and stomachs of U.S. consumers. ... of fresh peppers at an all-time high, only a fraction ... 70 percent of all fresh peppers consumed in the U.S. ...
Other Biology News:A new weapon in the fight against obesity and diabetes 2Coral reefs found growing in cold, deep ocean 2New hybrid plants could prompt more prodigious pepper production in Southwest 2New hybrid plants could prompt more prodigious pepper production in Southwest 3New hybrid plants could prompt more prodigious pepper production in Southwest 4
Applications: Epitope mapping, Mapping protein-protein contacts, Identification of enzyme substrates/inhibitors, Identification of receptor agonists/antagonists...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Request Info...
Biology Products: